These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1204 related items for PubMed ID: 27400880

  • 1. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM, Brauckhoff M, Schlichting E, Helset K, Svartberg J, Brauckhoff K, Mæhle L, Engebretsen LF, Sigstad E, Grøholt KK, Akslen LA, Jørgensen LH, Varhaug JE, Bjøro T.
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [Abstract] [Full Text] [Related]

  • 2. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW, Links TP, Rouwe CW, van der Wal JE, Hofstra RM, Plukker JT.
    Ned Tijdschr Geneeskd; 2006 Feb 11; 150(6):311-8. PubMed ID: 16503023
    [Abstract] [Full Text] [Related]

  • 3. Current understanding and management of medullary thyroid cancer.
    Roy M, Chen H, Sippel RS.
    Oncologist; 2013 Feb 11; 18(10):1093-100. PubMed ID: 24037980
    [Abstract] [Full Text] [Related]

  • 4. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells SA.
    J Pediatr Surg; 1996 Jan 11; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [Abstract] [Full Text] [Related]

  • 5. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
    Pelizzo MR, Torresan F, Boschin IM, Nacamulli D, Pennelli G, Barollo S, Rubello D, Mian C.
    Am J Clin Oncol; 2015 Oct 11; 38(5):508-13. PubMed ID: 24064755
    [Abstract] [Full Text] [Related]

  • 6. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
    Niederle B, Sebag F, Brauckhoff M.
    Langenbecks Arch Surg; 2014 Feb 11; 399(2):185-97. PubMed ID: 24297502
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.
    Qi XP, Zhao JQ, Du ZF, Yang RR, Ma JM, Fei J, Cheng J, Han JS, Jin HY, Chen ZG, Wang JQ, Yang YP, Ying RB, Chen XL, Liu WT, Zhao Y, Jiang HL, Zhang XN.
    Eur J Surg Oncol; 2013 Sep 11; 39(9):1007-12. PubMed ID: 23849459
    [Abstract] [Full Text] [Related]

  • 8. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
    Machens A, Lorenz K, Dralle H.
    Ann Surg; 2009 Aug 11; 250(2):305-10. PubMed ID: 19638924
    [Abstract] [Full Text] [Related]

  • 9. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
    Heizmann O, Haecker FM, Zumsteg U, Müller B, Oberholzer M, Oertli D.
    Eur J Surg Oncol; 2006 Feb 11; 32(1):98-102. PubMed ID: 16325365
    [Abstract] [Full Text] [Related]

  • 10. Medullary thyroid carcinoma.
    Pacini F, Castagna MG, Cipri C, Schlumberger M.
    Clin Oncol (R Coll Radiol); 2010 Aug 11; 22(6):475-85. PubMed ID: 20627492
    [Abstract] [Full Text] [Related]

  • 11. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R, Holzhausen HJ, Gimm O, Dralle H, Rath FW.
    Virchows Arch; 1998 Sep 11; 433(3):203-8. PubMed ID: 9769122
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells SA.
    N Engl J Med; 2005 Sep 15; 353(11):1105-13. PubMed ID: 16162881
    [Abstract] [Full Text] [Related]

  • 13. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.
    Cancer; 2002 Jan 15; 94(2):323-30. PubMed ID: 11900218
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines.
    Rohmer V, Vidal-Trecan G, Bourdelot A, Niccoli P, Murat A, Wemeau JL, Borson-Chazot F, Schvartz C, Tabarin A, Chabre O, Chabrier G, Caron P, Rodien P, Schlumberger M, Baudin E, Groupe Français des Tumeurs Endocrines.
    J Clin Endocrinol Metab; 2011 Mar 15; 96(3):E509-18. PubMed ID: 21190982
    [Abstract] [Full Text] [Related]

  • 15. Medullary Thyroid Carcinoma Associated with Germline RETK666N Mutation.
    Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Sellin RV, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJ.
    Thyroid; 2016 Dec 15; 26(12):1744-1751. PubMed ID: 27673361
    [Abstract] [Full Text] [Related]

  • 16. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A.
    Puñales MK, da Rocha AP, Meotti C, Gross JL, Maia AL.
    Thyroid; 2008 Dec 15; 18(12):1261-8. PubMed ID: 18991485
    [Abstract] [Full Text] [Related]

  • 17. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL, Gosnell J, Elston MS, Saurine TJ, Richardson AL, Delbridge LW, Aglen JV, Robinson BG.
    Clin Endocrinol (Oxf); 2005 Dec 15; 63(6):636-41. PubMed ID: 16343097
    [Abstract] [Full Text] [Related]

  • 18. Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.
    Lau GS, Lang BH, Lo CY, Tso A, Garcia-Barcelo MM, Tam PK, Lam KS.
    Hong Kong Med J; 2009 Oct 15; 15(5):326-31. PubMed ID: 19801688
    [Abstract] [Full Text] [Related]

  • 19. Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634.
    Gimm O, Ukkat J, Niederle BE, Weber T, Thanh PN, Brauckhoff M, Niederle B, Dralle H.
    World J Surg; 2004 Dec 15; 28(12):1312-6. PubMed ID: 15517481
    [Abstract] [Full Text] [Related]

  • 20. Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing.
    Pomares FJ, Rodríguez JM, Nicolás F, Sola J, Canteras M, Balsalobre M, Pascual M, Parrilla P, Tébar FJ.
    J Am Coll Surg; 2002 Nov 15; 195(5):630-4. PubMed ID: 12437249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.